{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T01:50:48Z","timestamp":1773453048864,"version":"3.50.1"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,13]],"date-time":"2019-06-13T00:00:00Z","timestamp":1560384000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Comprehensive Psychiatry"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.comppsych.2019.06.002","type":"journal-article","created":{"date-parts":[[2019,6,28]],"date-time":"2019-06-28T11:50:18Z","timestamp":1561722618000},"page":"27-32","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Is there a discrete negative symptom syndrome in people who use methamphetamine?"],"prefix":"10.1016","volume":"93","author":[{"given":"Alexandra","family":"Voce","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Burns","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Castle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bianca","family":"Calabria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca","family":"McKetin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.comppsych.2019.06.002_bb0005","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1001\/archpsyc.1973.04200010020003","article-title":"The experimental reproduction of amphetamine psychosis","volume":"29","author":"Bell","year":"1973","journal-title":"Arch Gen Psychiatry"},{"issue":"4","key":"10.1016\/j.comppsych.2019.06.002_bb0010","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.pnpbp.2011.01.014","article-title":"Comparisons of methamphetamine psychotic and schizophrenic symptoms: a differential item functioning analysis","volume":"35","author":"Srisurapanont","year":"2001","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.comppsych.2019.06.002_bb0015","first-page":"95","article-title":"The phenomenology of experimentally induced amphetamine psychosis-preliminary observations","volume":"2","author":"Angrist","year":"1970","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.comppsych.2019.06.002_bb0020","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1192\/bjp.117.541.661","article-title":"A rating scale for evaluation of the clinical course and symptomatology in amphetamine psychosis","volume":"117","author":"Jonsson","year":"1970","journal-title":"Br J Psychiatry"},{"issue":"12","key":"10.1016\/j.comppsych.2019.06.002_bb0025","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1097\/NMD.0000000000000059","article-title":"Predictors of persistent psychotic symptoms in persons with methamphetamine abuse receiving psychiatric treatment","volume":"201","author":"Lecomte","year":"2013","journal-title":"J Nerv Ment Dis"},{"key":"10.1016\/j.comppsych.2019.06.002_bb0030","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.drugalcdep.2016.01.018","article-title":"The profile of psychiatric symptoms exacerbated by methamphetamine use","volume":"161","author":"McKetin","year":"2016","journal-title":"Drug Alcohol Depend"},{"issue":"4","key":"10.1016\/j.comppsych.2019.06.002_bb0035","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1080\/10826084.2018.1521430","article-title":"A systematic review of the symptom profile and course of methamphetamine associated psychosis","volume":"54","author":"Voce","year":"2019","journal-title":"Subst. Use Misuse"},{"issue":"4","key":"10.1016\/j.comppsych.2019.06.002_bb0040","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1017\/S1461145703003675","article-title":"Psychotic symptoms in methamphetamine psychotic in-patients","volume":"6","author":"Srisurapanont","year":"2003","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.comppsych.2019.06.002_bb0045","series-title":"Diagnostic and statistical manual of mental disorders, five edition","author":"American Psychiatric Association","year":"2013"},{"key":"10.1016\/j.comppsych.2019.06.002_bb0050","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1097\/ADT.0b013e3181cf58f2","article-title":"Methamphetamine psychosis in Australia, Philippines, and Thailand: recommendations for acute care and clinical inpatient management","volume":"9","author":"Ali","year":"2010","journal-title":"Addict Disord Treat"},{"key":"10.1016\/j.comppsych.2019.06.002_bb0055","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s40263-013-0054-1","article-title":"Antipsychotic-induced metabolic and cardiovascular side effects in schizophrenia: a novel mechanistic hypothesis","volume":"27","author":"Scigliano","year":"2013","journal-title":"CNS Drugs"},{"issue":"1","key":"10.1016\/j.comppsych.2019.06.002_bb0060","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1192\/bjp.168.1.68","article-title":"Relationships among negative, positive, and depressive symptoms in schizophrenia and psychotic depression","volume":"168","author":"Sax","year":"1996","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.comppsych.2019.06.002_bb0065","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1192\/bjp.185.3.196","article-title":"Stimulant psychosis: systematic review","volume":"185","author":"Curran","year":"2004","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.comppsych.2019.06.002_bb0070","series-title":"Schizophrenia, 2nd edition","author":"Castle","year":"2015"},{"key":"10.1016\/j.comppsych.2019.06.002_bb0075","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.biopsych.2016.05.021","article-title":"An integrative perspective on the role of dopamine in schizophrenia","volume":"81","author":"Maia","year":"2017","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.comppsych.2019.06.002_bb0080","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1007\/s001270050026","article-title":"The psychometric properties of the Composite International Diagnostic Interview","volume":"33","author":"Andrews","year":"1998","journal-title":"Soc Psychiatry Psychiatr Epidemiol"},{"key":"10.1016\/j.comppsych.2019.06.002_bb0085","first-page":"594","article-title":"Manual for the expanded brief psychiatric rating scale","volume":"12","author":"Lukoff","year":"1986","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.comppsych.2019.06.002_bb0090","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2307\/2529310","article-title":"The measurement of observer agreement for categorical data","volume":"33","author":"Landis","year":"1977","journal-title":"Biometrics"},{"key":"10.1016\/j.comppsych.2019.06.002_bb0095","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1046\/j.1360-0443.1995.9056072.x","article-title":"The Severity of Dependence Scale (SDS) in English and Australian samples of heroin, cocaine and amphetamine users","volume":"90","author":"Gossop","year":"1995","journal-title":"Addiction"},{"key":"10.1016\/j.comppsych.2019.06.002_bb0100","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1360-0443.1997.tb02953.x","article-title":"Choosing a cut-off on the Severity of Dependence Scale (SDS) for amphetamine users","volume":"92","author":"Topp","year":"1997","journal-title":"Addiction"},{"key":"10.1016\/j.comppsych.2019.06.002_bb0105","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1017\/S0033291705005969","article-title":"The diagnostic interview for psychoses (DIP): development, reliability and applications","volume":"36","author":"Castle","year":"2006","journal-title":"Psychol Med"},{"key":"10.1016\/j.comppsych.2019.06.002_bb0110","series-title":"MPLUS version 7.2","author":"Muth\u00e9n","year":"2012"},{"key":"10.1016\/j.comppsych.2019.06.002_bb0115","series-title":"Using multivariate statistics","author":"Tabachnick","year":"2001"},{"key":"10.1016\/j.comppsych.2019.06.002_bb0120","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1093\/biomet\/88.3.767","article-title":"Testing the number of components in a normal mixture","volume":"88","author":"Lo","year":"2001","journal-title":"Biometrika"},{"key":"10.1016\/j.comppsych.2019.06.002_bb0125","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.csda.2004.11.004","article-title":"Evaluating latent class analysis models in qualitative phenotype identification","volume":"50","author":"Yang","year":"2006","journal-title":"Comput Stat Data Anal"},{"key":"10.1016\/j.comppsych.2019.06.002_bb0130","series-title":"Stata statistical software: release 14","author":"StataCorp","year":"2015"},{"issue":"3","key":"10.1016\/j.comppsych.2019.06.002_bb0135","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.drugalcdep.2012.11.016","article-title":"Methamphetamine use: a comprehensive review of molecular, preclinical and clinical findings","volume":"129","author":"Panenka","year":"2013","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.comppsych.2019.06.002_bb0140","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/npp.2012.179","article-title":"An evaluation of the evidence that methamphetamine abuse causes cognitive decline in humans","volume":"38","author":"Dean","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.comppsych.2019.06.002_bb0145","first-page":"531","article-title":"Chronic schizophrenia-like states in methamphetamine psychosis","volume":"44","author":"Tomiyama","year":"1990","journal-title":"Jpn J Psychiatry Neurol"},{"key":"10.1016\/j.comppsych.2019.06.002_bb0150","first-page":"388","article-title":"Six months follow-up of patients with methamphetamine psychosis","volume":"64","author":"Yeh","year":"2001","journal-title":"Chin Med J"},{"key":"10.1016\/j.comppsych.2019.06.002_bb0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.schres.2009.03.005","article-title":"Schizophrenia, \u201cjust the facts\u201d 4. Clinical features and conceptualization","volume":"110","author":"Tandon","year":"2009","journal-title":"Schizophr Res"},{"key":"10.1016\/j.comppsych.2019.06.002_bb0160","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1034\/j.1600-0447.2003.00059.x","article-title":"Dimensional vs. categorical diagnosis in psychosis","volume":"107","author":"Rosenman","year":"2003","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.comppsych.2019.06.002_bb0165","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1192\/bjp.161.3.335","article-title":"Are there more than two syndromes in schizophrenia? A critique of the positive\u2013negative dichotomy","volume":"161","author":"Peralta","year":"1992","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.comppsych.2019.06.002_bb0170","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1017\/S0033291700033808","article-title":"Psychopathological syndromes in the functional psychoses: associations with course and outcome","volume":"26","author":"Van Os","year":"1996","journal-title":"Psychol Med"},{"issue":"5","key":"10.1016\/j.comppsych.2019.06.002_bb0175","doi-asserted-by":"crossref","first-page":"231","DOI":"10.3109\/10673229709030550","article-title":"The self-medication hypothesis of substance use disorders: a reconsideration and recent applications","volume":"4","author":"Khantzian","year":"1997","journal-title":"Harv Rev Psychiatry"},{"key":"10.1016\/j.comppsych.2019.06.002_bb0180","doi-asserted-by":"crossref","first-page":"325","DOI":"10.4103\/0971-9962.193652","article-title":"Self-medication hypothesis in substance-abusing psychotic patients: can it help some subjects?","volume":"32","author":"Padhy","year":"2016","journal-title":"Indian J Social Psychiatry"},{"key":"10.1016\/j.comppsych.2019.06.002_bb0185","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/0376-8716(95)01171-9","article-title":"Levels and correlates of polydrug use among heroin users and regular amphetamine users","volume":"39","author":"Darke","year":"1995","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.comppsych.2019.06.002_bb0190","series-title":"Principles of pharmacology: the pathophysiologic basis of drug therapy","author":"Golan","year":"2008"},{"issue":"2","key":"10.1016\/j.comppsych.2019.06.002_bb0195","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s00213-008-1110-2","article-title":"Dysregulation of emotional response in current and abstinent heroin users: negative heightening and positive blunting","volume":"198","author":"de Arcos","year":"2008","journal-title":"Psychopharmacology"},{"issue":"6","key":"10.1016\/j.comppsych.2019.06.002_bb0200","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1097\/FBP.0000000000000164","article-title":"Drug effects on responses to emotional facial expressions: recent findings","volume":"26","author":"Miller","year":"2015","journal-title":"Behav Pharmacol"},{"issue":"2","key":"10.1016\/j.comppsych.2019.06.002_bb0205","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/j.1360-0443.2011.03634.x","article-title":"The effect of methadone on emotional reactivity","volume":"107","author":"Savvas","year":"2012","journal-title":"Addiction"},{"issue":"30","key":"10.1016\/j.comppsych.2019.06.002_bb0210","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.psychres.2016.04.059","article-title":"Factors affecting severity of positive and negative symptoms of psychosis in a polysubstance using population with psychostimulant dependence","volume":"240","author":"Willi","year":"2016","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.comppsych.2019.06.002_bb0215","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1176\/ps.2006.57.10.1468","article-title":"Diagnosing psychotic disorders in the emergency department in the context of substance use","volume":"57","author":"Schanzer","year":"2006","journal-title":"Psychiatr Serv"},{"key":"10.1016\/j.comppsych.2019.06.002_bb0220","doi-asserted-by":"crossref","first-page":"358","DOI":"10.4088\/JCP.v69n0304","article-title":"Substance-induced psychosis: a diagnostic conundrum","volume":"69","author":"Mathias","year":"2008","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.comppsych.2019.06.002_bb0225","series-title":"Guidelines for the medical management of patients with methamphetamine induced psychosis. Southern Adelaide Health Service, Australian Government","author":"McIver","year":"2017"},{"key":"10.1016\/j.comppsych.2019.06.002_bb0230","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0022-3956(98)00021-1","article-title":"Validity of the Composite International Diagnostic Interview (CIDI) psychosis module in a psychiatric setting","volume":"32","author":"Cooper","year":"1998","journal-title":"J Psychiatr Res"},{"issue":"1","key":"10.1016\/j.comppsych.2019.06.002_bb0235","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1037\/1082-989X.4.1.84","article-title":"Sample size in factor analysis","volume":"4","author":"MacCallum","year":"1999","journal-title":"Psychol Methods"},{"key":"10.1016\/j.comppsych.2019.06.002_bb0240","series-title":"Timeline Followback user's guide: a calendar method for assessing alcohol and drug use","author":"Sobell","year":"1996"}],"updated-by":[{"DOI":"10.1016\/j.comppsych.2021.152231","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000}}],"container-title":["Comprehensive Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010440X19300252?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010440X19300252?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,7]],"date-time":"2019-08-07T03:54:03Z","timestamp":1565150043000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010440X19300252"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":48,"alternative-id":["S0010440X19300252"],"URL":"https:\/\/doi.org\/10.1016\/j.comppsych.2019.06.002","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.comppsych.2021.152231","asserted-by":"object"}]},"ISSN":["0010-440X"],"issn-type":[{"value":"0010-440X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Is there a discrete negative symptom syndrome in people who use methamphetamine?","name":"articletitle","label":"Article Title"},{"value":"Comprehensive Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.comppsych.2019.06.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}